Tumor cells within these immune-enriched neighborhoods demonstrated PD-L1 positivity, and within the tumor area, we observed frequent interactions between PD-1+ T cells and PD-L1+ cells, as well as ICOS+ CD4+ T cells, indicating a more active, tumor-reactive phenotype [45]. The gene discussed is CD4; the disease is neoplasm.